Total Payments
$2,591
2024 Payments
$1,080
Companies
21
Transactions
139
Medicare Patients
1,489
Medicare Billing
$222,774
Payment Breakdown by Category
Food & Beverage$2,564 (99.0%)
Education$27.00 (1.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,564 | 137 | 99.0% |
| Education | $27.00 | 2 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $728.41 | 43 | $0 (2024) |
| Medtronic, Inc. | $550.50 | 26 | $0 (2024) |
| ABBVIE INC. | $308.13 | 13 | $0 (2024) |
| Collegium Pharmaceutical, Inc. | $179.16 | 8 | $0 (2024) |
| Valinor Pharma, LLC | $146.88 | 14 | $0 (2024) |
| SCILEX PHARMACEUTICALS INC. | $107.53 | 6 | $0 (2021) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $79.48 | 4 | $0 (2024) |
| Vertos Medical, Inc. | $71.06 | 4 | $0 (2024) |
| Braeburn Inc. | $69.75 | 3 | $0 (2024) |
| RedHill Biopharma Inc. | $59.31 | 3 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,080 | 56 | Abbott Laboratories ($341.96) |
| 2023 | $733.37 | 41 | Abbott Laboratories ($352.05) |
| 2022 | $316.31 | 20 | Medtronic, Inc. ($156.78) |
| 2021 | $394.89 | 18 | Medtronic, Inc. ($168.17) |
| 2020 | $66.61 | 4 | SCILEX PHARMACEUTICALS INC. ($66.61) |
All Payment Transactions
139 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $13.68 | General |
| Category: Neuromodulation | ||||||
| 12/16/2024 | Medtronic, Inc. | INCEPTIV (Device) | Food and Beverage | In-kind items and services | $37.25 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 12/12/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $59.78 | General |
| Category: Neuromodulation | ||||||
| 12/11/2024 | Valinor Pharma, LLC | MOVANTIK (Drug) | Food and Beverage | In-kind items and services | $20.17 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/03/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $24.52 | General |
| Category: Neuromodulation | ||||||
| 11/20/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $21.24 | General |
| Category: Opioid Analgesic | ||||||
| 11/19/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $22.95 | General |
| Category: Opioid Use Disorder | ||||||
| 11/13/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $29.86 | General |
| Category: Gastroenterology | ||||||
| 11/08/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $4.02 | General |
| Category: Neuromodulation | ||||||
| 10/29/2024 | Valinor Pharma, LLC | MOVANTIK (Drug) | Food and Beverage | In-kind items and services | $6.20 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/25/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $23.35 | General |
| 10/22/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $25.29 | General |
| Category: Opioid Use Disorder | ||||||
| 10/22/2024 | ABBVIE INC. | QULIPTA (Drug), BOTOX | Food and Beverage | In-kind items and services | $21.60 | General |
| Category: NEUROSCIENCE | ||||||
| 10/15/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $25.00 | General |
| Category: Opioid Analgesic | ||||||
| 10/15/2024 | Valinor Pharma, LLC | MOVANTIK (Drug) | Food and Beverage | In-kind items and services | $4.83 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/27/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $24.00 | General |
| Category: Neuromodulation | ||||||
| 09/27/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $5.34 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 09/24/2024 | Stryker Corporation | MILD DEVICE KIT (Device) | Food and Beverage | In-kind items and services | $22.53 | General |
| Category: INSTRUMENTS | ||||||
| 09/20/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $4.74 | General |
| Category: Neuromodulation | ||||||
| 09/18/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $5.77 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 09/17/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $21.51 | General |
| Category: Opioid Use Disorder | ||||||
| 09/12/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $6.01 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 09/05/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $21.64 | General |
| Category: Neuromodulation | ||||||
| 09/04/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $22.01 | General |
| Category: Neuromodulation | ||||||
| 08/27/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $15.01 | General |
| Category: Spinal Cord Neurostimulation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 515 | 684 | $147,392 | $41,346 |
| 2022 | 8 | 370 | 446 | $144,493 | $44,210 |
| 2021 | 5 | 306 | 549 | $241,924 | $68,997 |
| 2020 | 5 | 298 | 555 | $231,475 | $68,221 |
Total Patients
1,489
Total Services
2,234
Medicare Billing
$222,774
Procedure Codes
25
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 181 | 281 | $49,360 | $15,200 | 30.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 97 | 164 | $47,906 | $12,756 | 26.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 61 | 61 | $20,929 | $5,680 | 27.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 44 | 45 | $18,513 | $4,806 | 26.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 17 | 17 | $9,495 | $2,396 | 25.2% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 103 | 103 | $864.00 | $346.80 | 40.1% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2023 | 12 | 13 | $325.00 | $160.55 | 49.4% |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2022 | 58 | 71 | $39,618 | $17,146 | 43.3% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2022 | 84 | 116 | $41,412 | $7,097 | 17.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 82 | 100 | $17,950 | $5,655 | 31.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 45 | 51 | $21,821 | $4,083 | 18.7% |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2022 | 21 | 26 | $9,204 | $4,018 | 43.7% |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2022 | 14 | 16 | $7,184 | $3,146 | 43.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 28 | 28 | $7,000 | $2,931 | 41.9% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2022 | 38 | 38 | $304.00 | $133.00 | 43.8% |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2021 | 71 | 136 | $73,576 | $33,087 | 45.0% |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2021 | 60 | 70 | $30,450 | $13,912 | 45.7% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2021 | 85 | 208 | $71,968 | $12,739 | 17.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 55 | 82 | $46,002 | $6,462 | 14.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 35 | 53 | $19,928 | $2,797 | 14.0% |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2020 | 72 | 128 | $68,480 | $31,319 | 45.7% |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2020 | 57 | 86 | $36,980 | $16,901 | 45.7% |
| 80307 | Testing for presence of drug | Office | 2020 | 84 | 217 | $74,214 | $13,334 | 18.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 61 | 93 | $34,596 | $4,484 | 13.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 24 | 31 | $17,205 | $2,183 | 12.7% |
About Allison Thomas, NURSE PRACTITIONER
Allison Thomas, NURSE PRACTITIONER is a Nurse Practitioner healthcare provider based in Raleigh, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/14/2011. The National Provider Identifier (NPI) number assigned to this provider is 1235434739.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Allison Thomas, NURSE PRACTITIONER has received a total of $2,591 in payments from pharmaceutical and medical device companies, with $1,080 received in 2024. These payments were reported across 139 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($2,564).
As a Medicare-enrolled provider, Thomas has provided services to 1,489 Medicare beneficiaries, totaling 2,234 services with total Medicare billing of $222,774. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Ad
Practice Information
- Specialty Nurse Practitioner
- Other Specialties Pain Medicine, Adult Health
- Location Raleigh, NC
- Active Since 01/14/2011
- Last Updated 01/07/2024
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1235434739
Products in Payments
- PROCLAIM (Device) $542.05
- INTELLIS ADAPTIVESTIM (Device) $327.08
- INTELLIS (Device) $168.17
- ETERNA (Device) $166.50
- QULIPTA (Drug) $155.82
- MOVANTIK (Drug) $146.88
- ZTLido (Drug) $107.53
- Belbuca (Drug) $92.12
- RELISTOR (Drug) $79.48
- UBRELVY (Drug) $77.67
- BOTOX (Biological) $74.64
- mild Device Kit (Device) $71.06
- BRIXADI (Drug) $69.75
- XTAMPZA (Drug) $65.26
- Movantik (Drug) $59.31
- INCEPTIV (Device) $37.25
- NAPRELAN (Drug) $35.21
- Intracept (Device) $31.24
- SPRINT PNS System (Device) $24.97
- QUTENZA (Drug) $23.66
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Raleigh
Ms. Sandrivette Johnson, Fnp-C, FNP-C
Nurse Practitioner — Payments: $461,669
Nurse Practitioner $461,669
Holly Starnes, F.n.p.-C, F.N.P.-C
Nurse Practitioner — Payments: $46,397
Nurse Practitioner $46,397
Victoria Poillucci, Np, NP
Nurse Practitioner — Payments: $22,783
Nurse Practitioner $22,783
Carrie Lewis, Rn Msn Cpnp, RN MSN CPNP
Nurse Practitioner — Payments: $7,366
Nurse Practitioner $7,366
Ms. Priya Kos, N.p, N.P
Nurse Practitioner — Payments: $7,211
Nurse Practitioner $7,211
Miss. Caroline Obregon, Agnp-C, AGNP-C
Nurse Practitioner — Payments: $5,841
Nurse Practitioner $5,841